Yazar "Oral, A." seçeneğine göre listele
Listeleniyor 1 - 20 / 31
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe 1-year Predictive Value of Baseline Pediatric Renal Transplant Scintigraphy(Springer, 2018) Yazici, B.; Bulut, I. Kaplan; Oral, A.[No Abstract Available]Öğe 1-year Predictive Value Of Baseline Pediatric Renal Transplant Scintigraphy(Springer, 2018) Yazici, B.; Bulut, I. Kaplan; Oral, A.Öğe Analysis of Gastroesophageal Reflux Incidence in Pediatric Patients(Springer, 2005) Argon, M.; Mutlukoca, N.; Duygun, U.; Oral, A.Öğe The assessment of relation between clinic-pathologic findings and ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte in papillary thyroid carcinoma(Springer, 2018) Ceylan, Y.; Kumanlioglu, K.; Oral, A.; Ertan, Y.; Ozcan, Z.Öğe Atypical I-131 SPECT/CT Findings of Parotid Gland in two Patients with Differentiated Thyroid Carcinoma(Springer, 2013) Tugral, B.; Omur, O.; Oral, A.; Ozcan, Z.Öğe Clinical utility of somatostatin receptor scintigraphy: a retrospective analysis of one year's data(Springer, 2006) Yazici, B.; Oral, A.; Mutlukoca, N.; Erdim, O.; Burak, Z.Öğe Clinical value of metabolic PET parameters of primary vulvar carcinoma(Elsevier Espana Slu, 2021) Yanarates, A.; Budak, E.; Budak, A.; Inan, A. Hamdi; Kanmaz, A. Goksel; Oral, A.; Yazici, B.Purpose: We aim to establish the prognostic value of metabolic parameters of the primary tumor in patients diagnosed with vulvar squamous cell carcinoma (VSCC) who underwent a pretreatment F-18 FDG PET/CT scan. Materials and methods: This retrospective study included 47 patients with a his topathologically confirmed diagnosis of VSCC, and who underwent a F-18 FDG PET/CT scan prior to treatment. The disease stage and age at diagnosis, the maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume (WV) and total lesion glycolysis (TLG) values of the primary tumor, based on a baseline PET scan, were recorded. The relationship between these factors, and progression-free survival (PFS) and overall survival (OS) was evaluated. Results: The mean age of the 47 study patients was 69.6 +/- 1.9 years. Among the patients, 18 were in early stage of the disease and 29 were in the advanced stage. The age, and SUVmax, SUVmean, MTV and TLG values were statistically significantly associated with OS and PFS. Furthermore, it was noted that OS and PFS were significantly longer in the early stage patients than in the advanced stage patients, in patients with a tumor size >= 4 cm than those with a tumor size 4 cm, and in patients with a negative lymph node metastasis than those with a positive lymph node metastasis. Conclusion: Our findings suggest that PET parameters are prognostic factors for VSCC. To the best of our knowledge, this study is the first to investigate the prognostic value of the PET parameters of primary tumors in patients with VSCC, and as such, we believe it contributes to literature. (C) 2020 Sociedad Espanola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espana, S.L.U. All rights reserved.Öğe Comparison of FDG-PET/CT and Biopsy for Evaluation of Bone Marrow Involvement in Pediatric Lymphoma Patients(Springer, 2018) Oral, A.; Yazici, B.; Alcicek, S.; Demir, D.; Burak, Z.Öğe The Contributions of SPECT-CT to Planar Splenic Scintigraphy Using Tc-99m-Labeled Heat-Denatured Red Blood Cells(Springer, 2014) Oral, A.; Yazici, B.; Omur, O.; Akgun, A.Öğe The Contributions of SPECT-CT to Planar Whole Body Bone Scan(Springer, 2013) Oral, A.; Omur, O.; Tugral, B.; Tekin, E.; Argon, M.Öğe Correlation of quantitative indices of basal renal transplant scintigraphy with same day and 1-week graft function(Springer, 2016) Yazici, B.; Oral, A.; Akgun, A.Öğe Diffuse hepatic uptake of radioiodine on post-ablative and post-therapeutic whole-body I-131 scan(Springer, 2007) OemueR, Oe.; Akguen, A.; Sen, C.; Oral, A.; Oezcan, Z.Öğe The Effect of Vitamin D Levels and Fok 1 VDR Gene Polymorphism on Long Term Bone Health in Pediatric Cancer Survivors(Wiley, 2017) Cetingul, N.; Sivis, Z. Onder; Ozen, S.; Onay, H.; Goksen, D.; Burak, Z.; Oral, A.; Kantar, M.; Aksoylar, S.; Özkınay, FerdaÖğe Evaluation Of F-18 FDG PET/CT In Differentiated Thyroid Cancers(Springer, 2018) Yazici, B.; Alcicek, S.; Oral, A.; Akgun, A.; Kumanlioglu, K.Öğe Evaluation of F-18 FDG PET/CT in Differentiated Thyroid Cancers(Springer, 2018) Yazici, B.; Alcicek, S.; Oral, A.; Akgun, A.; Kumanlioglu, K.[No Abstract Available]Öğe Evaluation of Renal Transplant Scintigraphy in Diagnosis of Urinary Leakage(Springer, 2018) Yazici, B.; Oral, A.; Akgun, A.[No Abstract Available]Öğe Evaluation Of Renal Transplant Scintigraphy In Diagnosis Of Urinary Leakage(Springer, 2018) Yazici, B.; Oral, A.; Akgun, A.Öğe FDG PET/CT in the Evaluation of Multi-systemic Involvement in Erdheim Chester Disease(Springer, 2023) Guven, M.; Eroglu, M.; Oral, A.; Eraslan, C.; Ozcan, Z.[No abstract available]Öğe Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Extranodal Staging of Non-Hodgkin Lymphoma and Hodgkin Disease(Springer, 2013) Omur, O.; Yusufoglu, B.; Oral, A.; Ceylan, Y.Öğe Imaging with Tc-99m dextran in protein loosing enteropathy(Springer, 2006) Akgun, A.; Oral, A.; Taner, M.; Mutlukoca, N.
